What does MEDISAME do?

MEDISAME is a pharmacy in Stabroek. Private Limited, started on 3 January 2001, 1 establishment.

What is the address of MEDISAME?

The registered office of MEDISAME is located at Hoge Weg 6, 2940 Stabroek.

Is MEDISAME still active?

Yes. According to the CBE (30 October 2026) MEDISAME is active, legal situation “Normale toestand”, started on 3 January 2001.

Is MEDISAME registered on Peppol?

Yes, MEDISAME is registered on the Peppol network with ID 0208:0473695936.

What is the enterprise number of MEDISAME?

The enterprise number of MEDISAME is BE0473695936.

When was MEDISAME founded?

MEDISAME was founded on 3 January 2001.

Who are the directors of MEDISAME?

According to the 2025 annual accounts, the directors of MEDISAME are: Passiflora BV.

Is MEDISAME a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 January 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDISAME make in 2025?

MEDISAME posted a profit after taxes of € 8,149 in financial year 2025.

What is the revenue of MEDISAME?

As a small company, MEDISAME is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,805.

MEDISAME (Private Limited) - Stabroek - BE0473695936

Dossier MEDISAME, printed on 30 October 2026 from databakkes.be/en/0473695936/medisame. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.

Financials

Financial year 2025

MEDISAME from Stabroek, company number BE0473695936, closed financial year 2025 with a result of € 8,149 after tax. For that financial year MEDISAME recorded a gross margin of € 19,805 and equity of € -69,427. Compared with financial year 2024, the result moved from € 7,353 to € 8,149. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 4, 2026.

What it is worth Caution

€ -69,427

▲ € 8,149 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8,149

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 133,937

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -88,027.

Debts at end 2025

Bank debt

€ 245,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 590

▲ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,838

▼ 2% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 12,796 Gross margin 2022: € 12,796 First fiscal year in the series	€ 17,997 Gross margin 2023: € 17,997 ▲ 41% vs 2022 (€ 12,796) Favourable step	€ 18,715 Gross margin 2024: € 18,715 ▲ 4% vs 2023 (€ 17,997) Favourable step	€ 19,805 Gross margin 2025: € 19,805 ▲ 6% vs 2024 (€ 18,715) Favourable step	▲ 6%
Profit after taxes	€ 2,787 Profit after taxes 2022: € 2,787 First fiscal year in the series	€ 5,712 Profit after taxes 2023: € 5,712 ▲ 105% vs 2022 (€ 2,787) Favourable step	€ 7,353 Profit after taxes 2024: € 7,353 ▲ 29% vs 2023 (€ 5,712) Favourable step	€ 8,149 Profit after taxes 2025: € 8,149 ▲ 11% vs 2024 (€ 7,353) Favourable step	▲ 11%
Equity	€ -90,642 Equity 2022: € -90,642 First fiscal year in the series	€ -84,929 Equity 2023: € -84,929 ▲ € 5,712 vs 2022 (€ -90,642) Favourable step	€ -77,576 Equity 2024: € -77,576 ▲ € 7,353 vs 2023 (€ -84,929) Favourable step	€ -69,427 Equity 2025: € -69,427 ▲ € 8,149 vs 2024 (€ -77,576) Favourable step	▲ € 8,149
Total debts	€ 476,074 Total debts 2022: € 476,074 First fiscal year in the series	€ 256,873 Total debts 2023: € 256,873 ▼ 46% vs 2022 (€ 476,074) Favourable step	€ 254,321 Total debts 2024: € 254,321 ▼ 1% vs 2023 (€ 256,873) Favourable step	€ 254,216 Total debts 2025: € 254,216 Unchanged (€ 254,321) Favourable step
Cash	€ 331,387 Cash 2022: € 331,387 First fiscal year in the series	€ 115,027 Cash 2023: € 115,027 ▼ 65% vs 2022 (€ 331,387) Unfavourable step	€ 123,844 Cash 2024: € 123,844 ▲ 8% vs 2023 (€ 115,027) Favourable step	€ 133,937 Cash 2025: € 133,937 ▲ 8% vs 2024 (€ 123,844) Favourable step	▲ 8%
Land & buildings	€ 46,823 Land & buildings 2022: € 46,823 First fiscal year in the series	€ 44,896 Land & buildings 2023: € 44,896 ▼ 4% vs 2022 (€ 46,823) Unchanged	€ 44,725 Land & buildings 2024: € 44,725 Unchanged (€ 44,896) Unchanged	€ 42,612 Land & buildings 2025: € 42,612 ▼ 5% vs 2024 (€ 44,725) Unchanged	▼ 5%
Retained profit	€ -109,242 Retained profit 2022: € -109,242 First fiscal year in the series	€ -103,529 Retained profit 2023: € -103,529 ▲ € 5,712 vs 2022 (€ -109,242) Favourable step	€ -96,176 Retained profit 2024: € -96,176 ▲ € 7,353 vs 2023 (€ -103,529) Favourable step	€ -88,027 Retained profit 2025: € -88,027 ▲ € 8,149 vs 2024 (€ -96,176) Favourable step	▲ € 8,149
Bank debt	€ 250,000 Bank debt 2022: € 250,000 First fiscal year in the series	€ 250,000 Bank debt 2023: € 250,000 Unchanged (€ 250,000) Unchanged	€ 245,000 Bank debt 2024: € 245,000 ▼ 2% vs 2023 (€ 250,000) Favourable step	€ 245,000 Bank debt 2025: € 245,000 Unchanged (€ 245,000) Unchanged
Balance sheet total	€ 385,433 Balance sheet total 2022: € 385,433 First fiscal year in the series	€ 171,944 Balance sheet total 2023: € 171,944 ▼ 55% vs 2022 (€ 385,433) Unchanged	€ 176,745 Balance sheet total 2024: € 176,745 ▲ 3% vs 2023 (€ 171,944) Unchanged	€ 184,789 Balance sheet total 2025: € 184,789 ▲ 5% vs 2024 (€ 176,745) Unchanged	▲ 5%

Key figures of MEDISAME, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to MEDISAME?

What happened at MEDISAME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 4, 2026 New annual accounts for financial year 2025: profit of € 8,149 (▲ 11% vs 2024). Source: NBB ↗
May 3, 2001 New establishment in Stabroek. KBO
Jan 3, 2001 Start of the company according to the CBE. KBO

In short

From € 2,787 profit in 2022 to € 8,149 profit in 2025.

Best year ever: 2025, with € 8,149 profit.

Original PDFs at the National Bank ↗

Management

Passiflora BV

MEDISAME

Behind MEDISAME is Passiflora BV.

Directors

According to the 2025 annual accounts

Passiflora BV

Bestuurder · represented by Francis Nagels

Establishments

Establishment units

Physical locations of this company

Registered office

Hoge Weg 6

2940 Stabroek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

Gamen 1

GAMEN 2

WeCare4Youth

PASSIFLORA same network

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0473.695.936

VAT number

BE 0473.695.936

Registered office

Hoge Weg 6, 2940 Stabroek

Names & denominations

MEDISAME

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 January 2001

Peppol

Active · Active since 26 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISAME

Warning lights

Financials

What happened to MEDISAME?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions